Tratamiento endoscópico con cianoacrilato de fuga aérea persistente por fistula bronco-pleural en paciente con fibrosis pulmonar idiopática

Vega Sánchez, Blanca de; Roig Figueroa, Vicente.
Arch. bronconeumol. (Ed. impr.) ; 53(3): 164-165, mar. 2017. ilus
Artículo en Español | IBECS (España) | ID: ibc-161805

Documentos relacionados

  1. Pulmonary Fibrosis: Unveiling the Pathogenesis, Exploring Therapeutic Targets, and Advancements in Drug Delivery Strategies.
  2. Standigm ASK™: knowledge graph and artificial intelligence platform applied to target discovery in idiopathic pulmonary fibrosis.
  3. Revolutionizing the Treatment of Idiopathic Pulmonary Fibrosis: From Conventional Therapies to Advanced Drug Delivery Systems.
  4. An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond.
  5. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.
  6. Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis.
  7. Clinical course of suspected familial and sporadic idiopathic pulmonary fibrosis: Data from the PROOF-Next registry.
  8. Novel kinase 1 regulates CD8+T cells as a potential therapeutic mechanism for idiopathic pulmonary fibrosis.
  9. [Lipid metabolism in idiopathic pulmonary fibrosis].
  10. Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis.